Apple Opens a 200,000-Person U.S. Study of How People Use Health AI

Apple opened the Apple Health AI Usage Study in the United States on Nov. 15, 2026, working with OpenEvidence to enroll as many as 200,000 eligible adults.

Share this article

Featured image: an aerial view of Apple Park in Cupertino, California, in a June 2024 file photo. Photo: Nils Huenerfuerst, Wikimedia Commons, CC0 1.0. Cropped to 16:9.

Apple on Saturday, Nov. 15, 2026, opened the Apple Health AI Usage Study in the United States, a virtual research project it said will examine how people use conversational tools for health questions. The company is running the study with OpenEvidence, a clinical AI platform, and said it will enroll up to 200,000 adults.

Advertisement

In a newsroom post, Apple said the study is meant to measure trust, the quality of answers, comprehension and everyday health actions, and to inform “the responsible design of health AI experiences for Apple and the industry.” It said study data will not be used to train AI models.

200,000
Maximum number of U.S. participants Apple said the study will enroll
Age 21+
Minimum age Apple listed for eligible participants
iPhone 15 Pro or later
Device Apple said is required, with Apple Intelligence enabled and iOS 26 or later
Nov. 15, 2026
Date Apple published the announcement and said the study app became available

All four figures are from Apple’s Nov. 15, 2026, newsroom post, “Apple launches research study to explore the use of AI for health.”

What Apple said the Health AI study will do

Participants will use a study app, Apple said, to ask everyday health questions and to read answers written in “approachable language,” with “linked, peer-reviewed clinical citations that ground each response.” The company said OpenEvidence’s system draws on medical information from established sources including The New England Journal of Medicine, the Journal of the American Medical Association and Nature.

Sumbul Desai, M.D., Apple’s vice president of Health and Fitness, said in the announcement, “At Apple, we believe responsible innovation starts with scientific rigor and clinical grounding. Health is deeply personal, and conducting a dedicated research study is the most thoughtful way to understand how people engage with, comprehend, and evaluate health AI in everyday life.”

Robert M. Wachter, M.D., chair of the Department of Medicine at the University of California, San Francisco, was also quoted. “Patients and clinicians are both turning to AI, but the tools they use are being built and tested in separate worlds,” he said. “When patients and doctors draw on versions of the same trustworthy tools, patients arrive prepared, conversations improve, and next steps happen seamlessly.”

Apple said the study will also explore how health AI might help people prepare for visits with their own doctors. A footnote in the announcement said the study app “is not meant to diagnose or treat any condition, or replace the advice of medical professionals,” and that participants should consult a doctor or clinician to address health concerns or verify medical information.

The launch comes as other companies also try to put conversational systems into clinical or insurance settings. The Boston Report reported this week that Google launched Gemini for Healthcare, with a Massachusetts insurer among the early users, a separate product announcement that is not part of Apple’s study.

By the numbers: who Apple said can enroll

Apple limited the study to “up to 200,000 eligible participants age 21 and older across the United States.” To join, it said, a person must have “an Apple Intelligence-enabled iPhone (iPhone 15 Pro or later) running iOS 26 or later,” then download the study app and choose to enroll.

Those rules leave out anyone 20 or younger, anyone outside the United States, and anyone whose phone is older than an iPhone 15 Pro or is not running iOS 26 with Apple Intelligence turned on. Apple did not publish, in the newsroom post, how many people in the United States currently meet that device test, so the 200,000 cap should not be read as a share of all iPhone users.

Graphic of Apple Health AI Usage Study enrollment rules: Apple said it will enroll up to 200,000 U.S. participants age 21 or older who have an Apple Intelligence-enabled iPhone 15 Pro or later running iOS 26 or later
Source: Apple, “Apple launches research study to explore the use of AI for health,” Nov. 15, 2026. The study is a research project; Apple said the app is not meant to diagnose or treat any condition. Chart: The Boston Report.

Participants may choose to share HealthKit data types such as resting heart rate, activity, sleep or lab results, Apple said, so the study can look at how personal data “impacts relevance and understanding.” The company said participants “retain control over whether to share any HealthKit metrics or survey responses,” and that it has put in place security measures to protect the study data it maintains and the confidentiality of participants’ information.

Privacy limits Apple described, and what it did not say

Apple’s most specific privacy pledge in the announcement is that “study data will not be used to train AI models.” It also said the app has safety guardrails “intended to detect certain concerning questions and suggest that a participant follow up with a provider or other resources if needed.”

Advertisement

The newsroom post does not, by itself, give a study end date, a payment or incentive amount, or a public timetable for releasing results. It also does not say that the study will lead to a new health feature in Siri or the Health app. Those are open questions the announcement does not answer.

The design choice Apple did emphasize is clinical grounding: answers should come with citations, and consumer chatbots, the company said, “may at times offer responses that are incomplete or unclear.” That concern has been the subject of other evaluations of medical AI, including a Google health AI evaluation framework the Boston Report has previously described. Apple’s study is a user-research project, not a head-to-head benchmark against those tests.

OpenEvidence is described by Apple as a clinical AI platform “widely used by healthcare professionals.” The announcement does not include a user count or a financial term for the collaboration, and The Boston Report has not independently confirmed OpenEvidence’s professional market share.

What the announcement establishes, and what it does not

What Saturday’s post establishes is narrower, and still significant: Apple is recruiting as many as 200,000 U.S. adults, on recent iPhones, into a study of conversational health AI built with a clinical-citation platform, and it has said the resulting data will not be used to train models. It has also said the app is a research tool, not a diagnostic product.

Whether the findings later change Apple’s consumer health software is a question the company did not answer in the announcement. For now, the study sits alongside a wider field of AI news about how technology companies test medical uses of large language models, including work already reaching some Massachusetts patients through other firms’ products. Readers can also follow related coverage in our AI applications by industry guide.

Sources

Read next in Artificial Intelligence

Get The Boston Report Briefing

Our free weekly email with the most important stories from Boston and the world. Unsubscribe anytime.

Free. We never sell your address. Privacy policy

Get The Boston Report Briefing
Our free weekly email with the most important stories from Boston and the world. Unsubscribe anytime.
Sign up